RELAX-AHF Stirs Interest in Novel Drug for Acute Heart Failure

Published November 11, 2012

RELAX-AHF Stirs Interest In Novel Drug For Acute Heart Failure

Filed under: drug treatment programs in san francisco

Other heart failure cardioloigsts, including Mariel Jessup and Greg Fonarow, agreed that the mortality finding, if confirmed, would mean that serelaxin treatment would represent a genuine breakthrough in the treatment of acute heart failure. But, said …
Read more on Forbes

Cytokinetics to Present at the Lazard 9th Annual Healthcare Conference

Filed under: drug treatment programs in san francisco

South San Francisco, CA, November 7, 2012 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the Lazard 9 th Annual Healthcare Conference on Tuesday …
Read more on Reuters